| 产品名称： | JJR-1 |
|---|---|
| 商品货号： | TS202521 |
| Designations： | JJR-1 |
| GenBank Number： | L11353 |
| Species： | Homo sapiens, human |
| Depositors： | Massachusetts General Hospital, JF Gusella, JA Trofatter, Massachusetts General Hospital |
| Vector： | Construct size (kb): 5.300000190734863 |
| Insert： | DNA: cDNA Insert lengths(kb): 2.299999952316284 Tissue: frontal cortex Gene product: neurofibromatosis 2 (bilateral acoustic neuroma)(merlin, neurofibromatosis 2 tumor suppressor) NF2 |
| Insert Size (kb)： | 2.300 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--3.1, 2.4; PstI--3.5, 0.92, 0.54, 0.38; HindIII--3.5, 1.3, 0.74. The insert contains the following restriction sites (approximate kb from the 5 end): PstI--0.41, 1.3, 1.59, 1.82; HindIII--1.08, 1.71; PvuII--1.36, 1.58, 2.14. Contains the complete coding sequence (nt 220-2007). Detects transcripts of 7.0, 4.4 (weak), and 2.6 kb in diverse tissues. |
| References： | Trofatter JA, et al. A novel moesin-ezrin-radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800, 1993. PubMed: 8453669 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | JJR-1 |
|---|---|
| 商品货号： | TS202521 |
| Designations： | JJR-1 |
| GenBank Number： | L11353 |
| Species： | Homo sapiens, human |
| Depositors： | Massachusetts General Hospital, JF Gusella, JA Trofatter, Massachusetts General Hospital |
| Vector： | Construct size (kb): 5.300000190734863 |
| Insert： | DNA: cDNA Insert lengths(kb): 2.299999952316284 Tissue: frontal cortex Gene product: neurofibromatosis 2 (bilateral acoustic neuroma)(merlin, neurofibromatosis 2 tumor suppressor) NF2 |
| Insert Size (kb)： | 2.300 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--3.1, 2.4; PstI--3.5, 0.92, 0.54, 0.38; HindIII--3.5, 1.3, 0.74. The insert contains the following restriction sites (approximate kb from the 5 end): PstI--0.41, 1.3, 1.59, 1.82; HindIII--1.08, 1.71; PvuII--1.36, 1.58, 2.14. Contains the complete coding sequence (nt 220-2007). Detects transcripts of 7.0, 4.4 (weak), and 2.6 kb in diverse tissues. |
| References： | Trofatter JA, et al. A novel moesin-ezrin-radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800, 1993. PubMed: 8453669 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
